School of Dentistry Studies link between oral health and memory

  • Author: Health Informer
  • Filed under: Health News
  • Date: Jun 22,2009

Keeping your teeth brushed and flossed can cut down on gum disease, drastically reducing risk of heart attack and stroke, dentists have warned for years. Now researchers at West Virginia University have found a clean mouth may also help preserve memory.

The National Institutes of Health (NIH) has awarded a $1.3 million grant over four years to further build on studies linking gum disease and mild to moderate memory loss.

“Older people might want to know there’s more reason to keep their mouths clean — to brush and floss — than ever,” said Richard Crout, D.M.D., Ph.D., an expert on gum disease and associate dean for research in the WVU School of Dentistry. “You’ll not only be more likely to keep your teeth, but you’ll also reduce your risk of heart attack, stroke and memory loss.”

Crout will share the grant with gerontologist Bei Wu, Ph.D., formerly of WVU and now a researcher at the University of North Carolina; Brenda L. Plassman, Ph.D., of Duke University, a nationally recognized scientist in the field of memory research; and Jersey Liang, Ph.D., a professor at the University of Michigan. Wu is the principal investigator.

The team will look at health records over many years of several thousand Americans.

“This could have great implications for health of our aging populations,” Crout said. “With rates of Alzheimer’s skyrocketing, imagine the benefits of knowing that keeping the mouth free of infection could cut down on cases of dementia.”

The research builds on an ongoing study of West Virginians aged 70 and older. Working with the WVU School of Medicine, School of Dentistry researchers have given oral exams and memory tests to 270 elderly people in more than a dozen West Virginia counties.

Funded by a $419,000 two-year grant, they’ve discovered that about 23 percent of the group suffers from mild to moderate memory loss.

A blood draw is also part of the study for research subjects who agree.

“If you have a gum infection, you’ll have an increased level of inflammatory byproducts,” Crout explained. “We’re looking for markers in the blood that show inflammation to see if there is a link to memory problems. We’d like to go full circle and do an intervention — to clean up some of the problems in the mouth and then see if the inflammatory markers go down.”

Researchers don’t yet understand whether microorganisms in the mouth create health problems or whether the body’s inflammatory response is to blame. It may be a combination of both. Researchers also don’t know much about mild to moderate memory loss, even though the connection between severe dementia and gum disease is well-known, Crout said.

In the future, dentists may routinely administer memory tests to their older patients, he said.

“A dentist may see a longtime, older patient with an area of the mouth that’s showing signs of inflammation because of not being properly cleaned daily,” Crout said. “Many times we as clinicians, however, don’t think of this as due to a memory problem. The patient may not be flossing or brushing properly as we have instructed they should. But this research indicates that the problem may be due to memory loss as opposed to noncompliance.”

Source: West Virginia University Health Sciences Center


Candela’s Vbeam Laser Gives Millions of Post-Surgical Patients a New Sense of Freedom –

Candela Corporation announced that two studies have reported superior results on patients who benefited from the Candela Vbeam(R) laser treatments for bruising resulting from cosmetic procedures. The studies concluded that the Vbeam pulsed-dye laser significantly expedited the healing process, improved outcomes, and provided greater overall patient satisfaction.

A study published in the March/April 2009 edition of the Archives of Facial Plastic Surgery, entitled: “Pulsed-Dye Laser for Treating Ecchymoses After Facial Cosmetic Procedures” by DeFatta, R. J., Krishna, S., and Williams, E. F., III concluded that “the Vbeam laser treatment resulted in a 63% mean improvement in ecchymoses scores within forty-eight (48) to seventy-two (72) hours.”

The second study, a 2009 ASLMS abstract, entitled: “A Simple Solution to a Common Problem” evaluated the effectiveness and safety of the long-pulse PDL (the Vbeam) for the treatment of ecchymoses. In this study by Elizabeth Hale, M.D., Julie Karen, M.D., Chris Hunzeker, M.D., Elliot Weiss, M.D., Leonard Bernstein, M.D., Lori Brightman, M.D., Anne Chapas, M.D., and Roy Geronemus, M.D. results showed that twenty-four hours post-treatment with the Vbeam laser, the average improvement was 62% and 13% for treated and untreated bruises, respectively.

Edwin F. Williams, M.D., Director, The Williams Center Plastic Surgery Specialists, and nationally recognized plastic surgeon pioneered this breakthrough Vbeam treatment. “Anytime you penetrate the skin there is a potential for bruising and we find that it is the bruising which occurs after many of these procedures that prevents patients from getting out into the public. It is extremely difficult to cover these unsightly marks with make-up and bruising can last for a number of weeks,” said Dr. Williams. Dr. Williams continued, “After just one treatment with the Vbeam, our patients experience dramatic clearance of the injured blood vessels. This treatment is a significant differentiator to our practice and we are excited to finally be able to offer our patients a safe and easy treatment of bruising that works!”

Roy G. Geronemus, M.D., Director, Laser & Skin Surgery Center of New York, commented, “There are millions of surgical and injectable procedures performed every year which often have bruising as a side effect that can last up to two weeks.” Dr. Geronemus continued, “This is a significant new use for the Vbeam which was already our ‘workhorse’ laser because of its efficacy and safety profile for a wide variety of applications including skin rejuvenation, the treatment of rosacea, acne, diffuse redness, scars and more.”

For more information and to request copies of the studies, visit www.candelalaser.com.


Bone Cancer Research Trust calls for new treatments for bone cancer

  • Author: Health Informer
  • Filed under: Health News
  • Date: Jun 21,2009

The Bone Cancer Research Trust is calling for new treatments for bone cancers affecting children and young people. This includes osteosarcoma and Ewing’s sarcoma, the two most common forms of primary bone cancer.

A study funded by the Bone Cancer Research Trust published in 2009 shows that the survival of children and young adults with bone cancer in the UK has not improved for 20 years.(1) More research is urgently needed to find new treatments. When new treatments are developed, they must be introduced without delay to avoid any more young people dying of this disease. On average a young person cured of this disease would have another 60 years of life.

One new treatment for osteosarcoma that improves survival is currently being considered for funding by NICE. BCRT is asking that this drug be made available as quickly as possible.

Michael Francis, chairman of the BCRT said ‘Too many of the children and young people with bone cancer still die from their disease. We need to make bone cancer a priority and we urgently need more research to identify effective new treatments. The Government needs to play its part and streamline the process for introducing new treatments into the UK.’

To support people affected by bone cancer, the Bone Cancer Research Trust is holding an Awareness Week during 20 – 27 June 2009. The theme for the week is the need to improve survival for these young people: this means greater priority, more research and new treatments. The week will finish with the 3rd Conference for bone cancer patients and their supporters, to be held in St Albans on Saturday 27 June. The conference will cover recent research and will give patients and their families the opportunity to question experts in bone cancer.

Twenty eight year old Hannah Millington, from Bromsgrove, who has been treated for osteosarcoma says, “‘Awareness Week and the Patients’ and Supporters’ Conference are key events for patients. They are an opportunity to raise awareness about this awful disease and to meet other people who are affected. Bone cancer is quite rare and it is easy for young people with the illness to feel extremely isolated.”

The Awareness Week is supported by, the Teenage Cancer Trust, Sarcoma UK, Cancer 52 and the Rarer Cancers Forum.

Reference

(1): Incidence and survival of childhood bone cancer in northern England and the West Midlands, 1981-2002. Eyre et al. British Journal of Cancer. Volume 100, Issue 1. January, 2009

About bone cancer

The two commonest forms of bone cancer are osteosarcoma and Ewing’s sarcoma. Both of these cancers most commonly occur between the ages of 10 and 25. Because these cancers can spread to other parts of the body, even when the tumour is detected at a very small size, treatment includes chemotherapy. Chemotherapy is intended to destroy the tumour cells which have spread to the rest of the body and to shrink the main mass of tumour cells. Successful treatment also requires another form of treatment to the main mass of tumour. For osteosarcoma this is usually surgery to remove the main tumour and may involve replacing the affected bone with a metal alternative or amputation. Ewing’s sarcoma is similarly often treated with surgery, but treatment also includes radiotherapy which is intended to kill any residual cells. Around 400 patients are diagnosed each year in the UK with primary bone cancers.

Source: Bone Cancer Research Trust (BCRT)


Solution featured as part of the Premier healthcare alliance Innovation Celebration

HealthFrontier, Inc., together with its technology partner, et medical devices SpA, Italy, introduced a new innovation in web-enabled electrocardiogram (ECG) technology. The ecg@home(TM), small enough to fit in the palm of a hand, can record a 10-second ECG rhythm strip without electrode cables by just using the thumbs.

The ecg@home(TM) debuted at the Premier healthcare alliance Annual Breakthroughs Conference and Exhibition in Anaheim, CA. It was one of only 26 products selected for showcase at Premier’s inaugural Innovation Celebration, an event to celebrate advances in healthcare while highlighting healthcare industry suppliers committed to innovation and improving patient outcomes.

“The combination of advanced hardware and web-enabled telemedicine allows physicians and hospitals to review ECG reads soon after patients perform the test remotely in their own homes,” said Tony Uccello, VP of Product Development at HealthFrontier. “The ecg@home(TM) enables practitioners to provide better, more informed care for their patients without requiring time-consuming office visits. This new focus on portability and connectivity has many companies considering how these innovative technologies can add value to their products and services.”

The ecg@home(TM) is powered by an IT backbone known as the Remote Health Monitoring System (RHMS). HealthFrontier’s RHMS is a web-enabled software application that automatically receives, stores and forwards incoming ECG scans to a patient’s Electronic Medical Record, thus eliminating the need for paper printouts. This innovative technology is certified on Dell systems, ensuring easy and seamless connectivity from patient to physician systems. It will be available for purchase both as a stand alone unit and with Dell hardware through the Premier healthcare alliance and through Dell.

Also coinciding with the Innovation Celebration is HealthFrontier’s announcement of the microtel ecgAnywhere(TM), a compact, hand-held, 12-lead ECG device that is equipped to upload recorded ECG data via Bluetooth, USB or through trans-telephonic transmission.

Source: HealthFrontier, Inc.